Friday, June 30, 2023

July 01 2023 at 03:55AM Test Article 6/30/23 Draft 1.1

Test Article 6/30/23

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/mKWBO3U

June 30 2023 at 09:21PM OTP Events Meetings and Workshops

Office of Therapeutic Products Events, Meetings, and Workshops

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/RJKdyhG

June 30 2023 at 08:29PM FDA Roundup: June 30 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/fkar4MJ

June 30 2023 at 08:26PM Jobs at the Center for Biologics Evaluation and Research (CBER)

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jPEiAWL

June 30 2023 at 07:26PM ROCTAVIAN

Product information for ROCTAVIAN

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/RQYdzui

June 30 2023 at 06:43PM Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Office of Patient Affairs in the Office of Clinical Policy and Programs (OCPP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4GxpSig

Thursday, June 29, 2023

June 30 2023 at 12:01AM FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

FDA approves Roctavian, the first adeno-associated virus vector-based gene therapy for the treatment of adults with severe hemophilia A.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FU6lsWf

June 29 2023 at 09:29PM ABRYSVO

ABRYSVO is indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older.


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WQmrvBX

June 27 2023 at 11:24PM Know Your Treatment Options for COVID-19

Patients today have more treatment options in the battle against COVID-19. The FDA has approved drug treatments for COVID-19 and has authorized others for emergency use.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/t1fPwjc

June 29 2023 at 02:45PM Chronic Rhinosinusitis with Nasal Polyps: Developing Drugs for Treatment

Clinical / Medical

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/l6pue0j

Wednesday, June 28, 2023

June 28 2023 at 11:58PM FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes

The FDA approved Lantidra, the first cellular therapy for the treatment of adults with type 1 diabetes who are unable to approach average blood glucose levels because of current repeated episodes of severe hypoglycemia despite intensive diabetes management and education.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eOxrlNP

June 28 2023 at 10:43PM Principal Investigator: Molecular Biologist with Bioinformatics experience

The FDA’s Center for Biologics Evaluation and Research, Office of Blood Research and Review, Division of Emerging and Transfusion Transmitted Diseases is recruiting to fill a Senior Staff Fellow/Visiting Scientist position to serve as a Principal Investigator in the Laboratory of Emerging Pathogens.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KlvcXw5

June 28 2023 at 08:10PM Devices Guidances

This page lists Medical Device Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/PyIYHDl

June 28 2023 at 07:25PM BK220791 - e-Delphyn Donor

The e-Delphyn Donor is a web enabled modular computerized system intended to be used by trained personnel to aid in donor management.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/l0Qg3Ks

June 28 2023 at 06:46PM Marketing Category

This is the list of marketing categories which may be used in Structured Product Labeling (SPL) documents which are sent to FDA.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/i0OhqP3

Tuesday, June 27, 2023

June 27 2023 at 10:11PM Labeling and Promotion Guidances

This page lists Labeling and Promotion Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/cFrmQL0

June 27 2023 at 09:11PM FDA Roundup: June 27 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8AHjink

June 27 2023 at 05:18PM Towards Longer-Acting Factor VIII Products with Better Purity

A description of Andrey Sarafanov's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zRFOmuU

June 27 2023 at 02:49PM Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2023

This is the list of guidance topics CBER is considering for development during Calendar Year 2023 - UpdatedJune 2023

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/NaecHm0

June 27 2023 at 02:41PM BK220798 - NexSys PCS Plasma Collection System with ExpressPlus Technology

The NexSys PCS® plasma collection system with Express®Plus Technology is intended for use as an automated cell separator system and blood component collector in conjunction with single-use sterile disposable sets, with or without saline compensation.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Ba7tICZ

June 27 2023 at 02:10PM EUCYT Laboratories LLC - 607182 - 06/04/2020

Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/b3rTi9S

Monday, June 26, 2023

June 26 2023 at 03:46PM Montgomery Women's Medical Center PC dba Montgomery Fertility Center - 607345 - 05/14/2020

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/PUI3FeJ

June 26 2023 at 03:30PM North Coast Biologics - 607532 - 05/21/2020

Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/mZ9MoKz

June 26 2023 at 02:50PM BK230820 - Erytra Eflexis

Erytra Eflexis is a fully-automated analyzer designed to automate in vitro immunohematological testing of human blood utilizing DG Gel 8 cards technology, including Blood Grouping, Antigen Typing, Antibody Screening, Antibody Identification, Compatibility Tests, and Direct Antiglobulin Tests.


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6AZeV1K

June 23 2023 at 02:32PM Alternative Procedures for the Manufacture of Cold-Stored Platelets Intended for the Treatment of Active Bleeding when Conventional Platelets Are Not Available or Their Use Is Not Practical

This notice is being issued under 21 CFR 640.120(b) to respond to a public health need and address the urgent and immediate need for platelets for the treatment of active bleeding when conventional platelets are not available, or their use is not practical.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/A59yQ82

Thursday, June 22, 2023

June 22 2023 at 10:57PM Consumer Updates

Science-based health and safety information you can trust.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/AQKRFTX

June 22 2023 at 08:04PM FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy

FDA Approves Elevidys, a gene therapy for the treatment of pediatric patients 4 through 5 years of age with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who do not have a pre-existing reason why they cannot receive this therapy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/SXoN8nL

Wednesday, June 21, 2023

June 21 2023 at 09:30PM Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Office of Patient Affairs draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/GF8caHn

June 20 2023 at 07:33PM Premarket Approvals and Humanitarian Device Exemptions with Supporting Documents

list includes applications for which we have approval documents available, and reflects the information as of the approval date. It is not updated with regard to applicant or application status changes. Information is arranged in alphabetical order by the name of the applicant.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rOa24n3

Tuesday, June 20, 2023

June 20 2023 at 10:40PM IDELVION

Product approval information is indicated for children and adults with hemophilia B (congenital Factor IX deficiency) for 1) On-demand control and prevention of bleeding episodes; 2) Perioperative management of bleeding; 3) Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tX2RYUD

June 20 2023 at 09:35PM FDA Roundup: June 20 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ybT3wvk

June 20 2023 at 08:39PM Drugs@FDA Data Files

Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/owWPFxm

June 20 2023 at 03:29PM Drug-Drug Interaction Assessment for Therapeutic Proteins Guidance for Industry

Clinical Pharmacology

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KFThrgI

June 15 2023 at 08:07PM Industry (Biologics)

CBER’s Manufacturers Assistance and Technical Training Branch provides assistance and training to industry, including large and small manufacturers and trade associations, and to respond to requests for information regarding CBER policies and procedures.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Z75EMqB

June 15 2023 at 06:32PM Roster of the Blood Products Advisory Committee

This is the Roster of the Blood Products Advisory Committee (BPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dyiu7qJ

June 15 2023 at 04:45PM BOOSTRIX

Boostrix is a product approval indicated for Booster immunization against tetanus, diphtheria and pertussis as a single dose in individuals 10 years of age and older

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/DrR0dSz

June 14 2023 at 06:44PM Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products - 04/27/2023

Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual public listening meeting to solicit input on methods and approaches (e.g., use of real-world evidence (RWE), registries) for capturing post approval safety and efficacy data for cell and gene therapy products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/cS1IP9Q

June 13 2023 at 08:09PM Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Office of Patient Affairs in the Office of Clinical Policy and Programs (OCPP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bkVHDQL

Tuesday, June 13, 2023

June 13 2023 at 09:22PM FDA Roundup: June 13 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/OGVedhX

June 13, 2023 at 08:02PM Reproductive Technologies, Inc. - 594292 - 11/06/2019

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ocj7QFC

June 13, 2023 at 08:01PM Reproductive Technologies, Inc. - 594292 - 12/03/2021

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/pI6r9jC

June 13, 2023 at 03:21PM VYJUVEK

Indicated for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/kXPDG4g

June 13, 2023 at 02:56PM Content of Premarket Submissions for Device Software Functions

The guidance describes FDA’s thinking on recommended documentation included in premarket submissions for FDA’s evaluation of the safety and effectiveness of device software functions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7HFDb6x

Monday, June 12, 2023

June 12, 2023 at 10:16PM AFSTYLA

AFSTYLA, Antihemophilic Factor (Recombinant), Single Chain, is a recombinant, antihemophilic factor indicated in adults and children with hemophilia A (congenital Factor VIII deficiency) for:
• On-demand treatment and control of bleeding episodes,
• Routine prophylaxis to reduce the frequency of bleeding episodes,
• Perioperative management of bleeding.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7sDgrAZ

June 12, 2023 at 10:04PM Antimicrobial Resistance Information from FDA

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KwnCSIB

June 12, 2023 at 03:31PM PREA Non-Compliance Letters

PREA Non-Compliance Letters

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/GQ2Sb1t

June 12, 2023 at 03:07PM Jobs at the Center for Biologics Evaluation and Research (CBER)

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Mc38TIr

June 12, 2023 at 02:57PM Regenerative Medicine Fellowship under the Service Fellowship Program for CBER

Regenerative medicine is an interdisciplinary field, which aims to repair diseased or damaged tissues using biological or cell-based technologies. This rapidly growing area of biomedical research encompasses cell biology, tissue engineering, drug delivery, and advanced manufacturing, among others.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/RPVF9we

June 12, 2023 at 01:46PM Vaccines and Related Biological Products Advisory Committee June 15, 2023 Meeting Announcement - 06/15/2023

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting June 15, 2023 announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Is3k1SH

Friday, June 9, 2023

June 09, 2023 at 09:27PM FDA Roundup: June 9, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/p94ELij

June 09, 2023 at 07:24PM Vaccines and Related Biological Products Advisory Committee May 18, 2023 Meeting Announcement - 05/18/2023

This is the main landing page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) May 18, 2023 Meeting announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/lOIsQv9

June 09, 2023 at 06:11PM CBER-Regulated Products: Shortages and Discontinuations

A CBER-regulated product shortage occurs when a CBER-regulated product is not commercially available in sufficient quantity to meet the demand.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/J1xhwA2

Tuesday, June 6, 2023

June 06, 2023 at 05:54PM Novavax COVID-19 Vaccine, Adjuvanted

Novavax COVID-19 Vaccine, Adjuvanted

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/kG1IfSV

June 06, 2023 at 05:52PM Blood Products Advisory Committee April 26, 2023 Meeting Announcement - 04/26/2023

This is the main page for the Blood Products Advisory Committee April 26, 2023 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/sJ4AVKF

Monday, June 5, 2023

June 05, 2023 at 03:02PM Roster of the Vaccines and Related Biological Products Advisory Committee

This is the Roster of the Vaccines and Related Biological Products Advisory Committee

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7hxfsZk

June 05, 2023 at 02:22PM Antimicrobial Resistance Information from FDA

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/hducpxX

Friday, June 2, 2023

June 02, 2023 at 09:45PM FDA Roundup: June 2, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ay6cl9w

June 02, 2023 at 08:16PM Clinical Guidances

This page lists Clinical Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ZER6An5

June 02, 2023 at 06:38PM Vaccines and Related Biological Products Advisory Committee May 18, 2023 Meeting Announcement - 05/18/2023

This is the main landing page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) May 18, 2023 Meeting announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ks54IXM

June 02, 2023 at 06:32PM Cellular, Tissue, and Gene Therapies Advisory Committee May 12, 2023 Meeting Announcement - 05/12/2023

This is the main landing page for the CBER Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) May 12, 2023 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vrA2FLZ

June 02, 2023 at 02:00PM Drug-Drug Interaction Assessment for Therapeutic Proteins Guidance for Industry

Clinical Pharmacology

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/e1j8lYO

May 31, 2023 at 07:50PM Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program

This guidance describes the mechanisms available through which submitters can request FDA feedback regarding potential or planned medical device submissions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/9qvsSr3

Thursday, June 1, 2023

June 02, 2023 at 12:14AM Janssen COVID-19 Vaccine

Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dqEThoJ

June 01, 2023 at 07:14PM Vaccines and Related Biological Products Advisory Committee June 15, 2023 Meeting Announcement - 06/15/2023

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting June 15, 2023 announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FHWj29U

June 01, 2023 at 06:38PM Vaccines Licensed for Use in the United States

The product name and trade name of vaccines licensed for use in the United States.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3HbKsjQ

June 01, 2023 at 05:16AM Licensed Biological Products with Supporting Documents

Licensed biological products with supporting documents is arranged alphabetically by the proper name of the product(s). Information is provided for original product approvals, new indications, and the current package insert.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/EoJGN6r

June 01, 2023 at 04:45PM Consumer Updates

Science-based health and safety information you can trust.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/f1UybSN

June 01, 2023 at 12:55PM FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes - 05/16/2023

FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/gOUFWV8